Literature DB >> 10642678

A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies.

V Usha1, T V Gopalakrishnan Nair.   

Abstract

BACKGROUND: The conventional antiscabietics have poor compliance. Ivermectin, an oral antiparasitic drug, has been shown to be an effective scabicide and could be a useful substitute.
OBJECTIVE: This study compares the efficacy of oral ivermectin with topical permethrin cream in the treatment of scabies.
METHODS: Eighty-five consecutive patients were randomized into 2 groups. Forty patients and their family contacts received 200 microg/kg body weight of ivermectin, and another 45 patients and their family contacts received a single overnight topical application of 5% permethrin cream. Patients were followed up at intervals of 1, 2, 4, and 8 weeks.
RESULTS: A single dose of ivermectin provided a cure rate of 70%, which increased to 95% with 2 doses at a 2-week interval. A single application of permethrin was effective in 97.8% of patients. One (2.2%) patient responded to 2 applications at a 2-week interval. Permethrin-treated patients recovered earlier.
CONCLUSION: A single application of permethrin is superior to a single dose of ivermectin. Two doses of ivermectin is as effective as a single application of permethrin. The temporal dissociation in clinical response suggests that ivermectin may not be effective against all the stages in the life cycle of the parasite.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10642678     DOI: 10.1016/S0190-9622(00)90131-2

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  25 in total

1.  Dermatologic Infectious Diseases in International Travelers.

Authors:  Mary E. Wilson; Lin H. Chen
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

Review 2.  Scabies: diagnosis and treatment.

Authors:  Graham Johnston; Mike Sladden
Journal:  BMJ       Date:  2005-09-17

Review 3.  More common skin infections in children.

Authors:  Michael J Sladden; Graham A Johnston
Journal:  BMJ       Date:  2005-05-21

Review 4.  [Scabies].

Authors:  C Hafner
Journal:  Hautarzt       Date:  2009-02       Impact factor: 0.751

5.  Scabies management.

Authors: 
Journal:  Paediatr Child Health       Date:  2001-12       Impact factor: 2.253

6.  Ivermectin worthy of further investigation.

Authors:  Andrew C Steer; Therese Kearns; Ross M Andrews; James S McCarthy; Jonathan R Carapetis; Bart J Currie
Journal:  Bull World Health Organ       Date:  2009-10       Impact factor: 9.408

7.  Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial.

Authors:  Fatimata Ly; Eric Caumes; Cheick Ahmet Tidiane Ndaw; Bassirou Ndiaye; Antoine Mahé
Journal:  Bull World Health Organ       Date:  2009-06       Impact factor: 9.408

Review 8.  The Treatment of Scabies.

Authors:  Corinna Dressler; Stefanie Rosumeck; Cord Sunderkötter; Ricardo Niklas Werner; Alexander Nast
Journal:  Dtsch Arztebl Int       Date:  2016-11-14       Impact factor: 5.594

9.  Diagnosis, prevention, and treatment of scabies.

Authors:  Luis Shimose; L Silvia Munoz-Price
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

10.  Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies.

Authors:  Narendra P Bachewar; Vijay R Thawani; Smita N Mali; Kunda J Gharpure; Vaishali P Shingade; Ganesh N Dakhale
Journal:  Indian J Pharmacol       Date:  2009-02       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.